Heterogeneity in treatment outcomes and incomplete recovery in first episode psychosis: does one size fit all?

Siân Lowri Griffiths*, Paris Alexandros Lalousis, Stephen J. Wood, Rachel Upthegrove

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

62 Downloads (Pure)

Abstract

The heterogeneity in recovery outcomes for individuals with First Episode Psychosis (FEP) calls for a strong evidence base to inform practice at an individual level. Between 19–89% of young people with FEP have an incomplete recovery despite gold-standard evidence-based treatments, suggesting current service models, which adopt a ‘one-size fits all’ approach, may not be addressing the needs of many young people with psychosis. The lack of consistent terminology to define key concepts such as recovery and treatment resistance, the multidimensional nature of these concepts, and common comorbid symptoms are some of the challenges faced by the field in delineating heterogeneity in recovery outcomes. The lack of robust markers for incomplete recovery also results in potential delay in delivering prompt, and effective treatments to individuals at greatest risk. There is a clear need to adopt a stratified approach to care where interventions are targeted at subgroups of patients, and ultimately at the individual level. Novel machine learning, using large, representative data from a range of modalities, may aid in the parsing of heterogeneity, and provide greater precision and sophistication in identifying those on a pathway to incomplete recovery.

Original languageEnglish
Article number485
Number of pages6
JournalTranslational Psychiatry
Volume12
Issue number1
DOIs
Publication statusPublished - 17 Nov 2022

Bibliographical note

Funding Information:
The authors report the following conflicts of interest: RU and SJW report grants from Medical Research Council, European Commission—Research: The Seventh Framework Programme, and National Institute for Health Research. SJW also has grants from National Health and Medical Research Council Australia, and the Medical Research Future Fund. Outside of the submitted work, RU has personal fees from Sunovion, and SJW has personal fees from Biogen.

Publisher Copyright:
© 2022, The Author(s).

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Biological Psychiatry

Fingerprint

Dive into the research topics of 'Heterogeneity in treatment outcomes and incomplete recovery in first episode psychosis: does one size fit all?'. Together they form a unique fingerprint.

Cite this